Parkinson's disease other imaging findings: Difference between revisions
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
'''PET scan''': In [[PET scan]] we can see that the uptake of [18F]-flurodopa tracer in reduce in the [[Caudate nucleus|caudate]] and [[putamen]] in [[Parkinson's disease|PD]] patients. | |||
'''DaTscan''': This technique can help us differentiate healthy individuals or patients with [[essential tremor]] from diseases with nigrostriatal degeneration ([[Parkinson's disease|PD]], [[Multiple system atrophy|MSA]], [[Progressive supranuclear palsy|PSP]], and cortical degeneration). | |||
'''Sonography''': In [[sonography]] of [[Parkinson's disease|PD]] patient’s [[brain]] we can see hyperechogenicity of the [[STN]]. | |||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
Latest revision as of 19:09, 28 November 2018
|
Parkinson's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Parkinson's disease other imaging findings On the Web |
|
American Roentgen Ray Society Images of Parkinson's disease other imaging findings |
|
Risk calculators and risk factors for Parkinson's disease other imaging findings |
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
PET scan: In PET scan we can see that the uptake of [18F]-flurodopa tracer in reduce in the caudate and putamen in PD patients.
DaTscan: This technique can help us differentiate healthy individuals or patients with essential tremor from diseases with nigrostriatal degeneration (PD, MSA, PSP, and cortical degeneration).
Sonography: In sonography of PD patient’s brain we can see hyperechogenicity of the STN.
Other Imaging Findings
- PET scan: In PET scan we can see that the uptake of [18F]-flurodopa tracer in reduce in the caudate and putamen in PD patients.[1]
- DaTscan: This technique can help us differentiate healthy individuals or patients with essential tremor from diseases with nigrostriatal degeneration (PD, MSA, PSP, and cortical degeneration).[2][3]
- Sonography: In sonography of PD patient’s brain we can see hyperechogenicity of the STN.[4]
References
- ↑ Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, van Oostrom JC, Leenders KL (October 2010). "Typical cerebral metabolic patterns in neurodegenerative brain diseases". Mov. Disord. 25 (14): 2395–404. doi:10.1002/mds.23291. PMID 20669302.
- ↑ Stoessl AJ, Martin WW, McKeown MJ, Sossi V (November 2011). "Advances in imaging in Parkinson's disease". Lancet Neurol. 10 (11): 987–1001. doi:10.1016/S1474-4422(11)70214-9. PMID 22014434.
- ↑ Kägi G, Bhatia KP, Tolosa E (January 2010). "The role of DAT-SPECT in movement disorders". J. Neurol. Neurosurg. Psychiatry. 81 (1): 5–12. doi:10.1136/jnnp.2008.157370. PMID 20019219.
- ↑ Gaenslen A, Unmuth B, Godau J, Liepelt I, Di Santo A, Schweitzer KJ, Gasser T, Machulla HJ, Reimold M, Marek K, Berg D (May 2008). "The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study". Lancet Neurol. 7 (5): 417–24. doi:10.1016/S1474-4422(08)70067-X. PMID 18394965.